ZINC8034121 (Cysteamine)
| Added | Available | Since | Mwt | logP | Heavy Atoms | Tranche | Download |
|---|---|---|---|---|---|---|---|
| 2006-06-28 | In-Stock | 2015-08-07 | 77.152 | -0.125 | 4 | ABEA |
|
Find Decoys
Available 3D Representations
| pH range | Net charge |
H-bond donors |
H-bond acceptors |
tPSA Ų | Rotatable bonds |
Apolar desolvationkcal/mol |
Polar desolvationkcal/mol |
Download |
|---|---|---|---|---|---|---|---|---|
| Reference | 1 | 2 | 1 | 27 | 1 | -0.29 | -43.46 |
|
143 Items Total
Vendors (64 Total)
-
- 21200
- 2839
-
- LQ0646
- LX2357
-
- HY-77591
- HY-77591A
-
- CUR-0000633
- CUR-0101235
-
- DB-043323
- DB-053562
-
- BBS-00020848
-
- SC-15256
- SC-18413
-
- SC-15256
- SC-18413
-
- 50A408589
-
- OR010910
- OR012144
- OR036346
- OR109744
- OR109745
- OR149615
- OR176763
- OR195450
- OR211266
- OR218075
- OR229794
- OR250658
- OR254914
- OR335774
- OR382377
-
- LN00193207
- LN00243152
- LN01739988
- LN01741074
49 Items Total
Annotated Catalogs (34 Total)
-
- Selleck-18-H-7
- Spectrum-11-D-5
-
- 01504226
-
- 01504226
-
- 01504226
-
- BIE047648
-
- CPD-239
-
- DHL
- SEA
-
- SW00034
Activities based on ChEMBL 20
There is no known activity for this compound.
Run SEA
SEA Predictions based on ChEMBL 20
Find All
Interesting Analogs
Substance Rings
This compound has no patterns of concern (or they have not yet been computed).
Molecular Patterns (Warnings, etc.)
References
This substance is not reported in any publications per ChEMBL.
View All 18 Clinical Trials
| Trial ID | Title | Status | Phase | Start Date | Condition(s) | Drug(s) |
|---|---|---|---|---|---|---|
| NCT00002110 | A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease | Completed | Phase 2 | Unknown |
HIV Infections
|
Cysteamine
Zidovudine
|
| NCT01571128 | Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth) | Recruiting | Phase 4 | Nov 2014 |
Adolescent Behavior
Gender
HIV
|
Pre-Exposure Prophylaxis (Females)
Male-Specific Intervention Package
Female-Specific Intervention Package
Cash Transfer Cohort (Females)
|
| NCT02212431 | First Study of Oral Cysteamine in Cystic Fibrosis | Recruiting | Phase 1/Phase 2 | Aug 2014 |
Cystic Fibrosis
|
Cysteamine
|
| NCT02023866 | Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease | Recruiting | Phase 2/Phase 3 | Jun 2014 |
Inherited Mitochondrial Disease, Including Leigh Syndrome
|
Cysteamine Bitartrate Delayed-release Capsules (RP103)
|
| NCT01733316 | Open-Label Safety & Superior Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cystinosis | Active, not recruiting | Phase 3 | Jan 2013 |
Cystinosis
|
RP103 Q12H
Cystagon Q6H
|
Additional Identifiers (Synonyms/CAS Numbers/etc.)
- CAS Numbers
- ATC Code(s)
- WHO Name(s)
- Molecule Names
-
- CYSTEAMINE
- CYSTEAMINE BITARTRATE
- CYSTEAMINE HYDROCHLORIDE
- Synonyms
-
- Cysteamine
- Cysteamine
- 2-Aminoethyl mercaptan
- 2-Mercaptoethanamine
- (2-Mercaptoethyl)amine
- Aminoethyl mercaptan
- b-Aminoethanethiol
- b-Aminoethylthiol
- Becaptan
- beta-Aminoethanethiol
- beta-Aminoethylthiol
- beta-Mercaptoethylamine
- b-Mercaptoethylamine
- CASH
- Cisteamina
- Cysteamide
- Cysteamin
- 2-Amino-1-ethanethiol
- Cysteinamine
- Decarboxycysteine
- Ethanethiolamine
- Lambraten
- Lambratene
- Mecramine
- Mercamin
- Mercamine
- Mercaptamin
- Mercaptamine
- Merkamin
- Riacon
- Thioethanolamine
- Cystagon
- Cystaran
- 2-Aminoethanethiol